These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 28097690)
1. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. Khatun F; Stephenson RJ; Toth I Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690 [TBL] [Abstract][Full Text] [Related]
4. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Berti F; Micoli F Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591 [TBL] [Abstract][Full Text] [Related]
6. Recent developments in bacterial conjugate vaccines. Goldblatt D J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559 [TBL] [Abstract][Full Text] [Related]
7. Bacterial polysaccharides as vaccines--immunity and chemical characterization. Lee CJ; Lee LH; Lu CS; Wu A Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815 [TBL] [Abstract][Full Text] [Related]
8. Glycoconjugate vaccines: an update. Vella M; Pace D Expert Opin Biol Ther; 2015 Apr; 15(4):529-46. PubMed ID: 25496172 [TBL] [Abstract][Full Text] [Related]
9. Preclinical studies on new proteins as carrier for glycoconjugate vaccines. Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455 [TBL] [Abstract][Full Text] [Related]
10. Oligosaccharide Antigen Conjugation to Carrier Proteins to Formulate Glycoconjugate Vaccines. Smith BR; Guo Z Methods Mol Biol; 2021; 2183():305-312. PubMed ID: 32959250 [TBL] [Abstract][Full Text] [Related]
12. Novel strategies for development of next-generation glycoconjugate vaccines. Avci FY Curr Top Med Chem; 2013; 13(20):2535-40. PubMed ID: 24066893 [TBL] [Abstract][Full Text] [Related]
13. [Recent advance in carbohydrate-based cancer vaccines]. Huo CX; Ye XS Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748 [TBL] [Abstract][Full Text] [Related]
14. Semisynthetic glycoconjugate vaccine candidate against Lisboa MP; Khan N; Martin C; Xu FF; Reppe K; Geissner A; Govindan S; Witzenrath M; Pereira CL; Seeberger PH Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11063-11068. PubMed ID: 28973947 [TBL] [Abstract][Full Text] [Related]
15. Recent mechanistic insights on glycoconjugate vaccines and future perspectives. Berti F; Adamo R ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819 [TBL] [Abstract][Full Text] [Related]
16. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine. Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628 [TBL] [Abstract][Full Text] [Related]